RESMED INC — Director's Dealing 2024

Oct 9, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-10-07

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-07	ResMed Common Stock	M	14683	$84.98	Acquired	478852	Direct
2024-10-07	ResMed Common Stock	S	14683	$231.9149	Disposed	464169	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-07	ResMed Common Stock Options	$84.98	M	14683	Disposed	2024-11-16	ResMed Common Stock (14683)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	0	Indirect
ResMed Common Stock	4090	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

F2: This transaction was executed in multiple trades at prices ranging from $230.66 - $234.70 The price reported above reflects the weighted average sale price.

F3: Represents date options first became exercisable. Options vest 1/3 per year.